Psychemedics Shares Outstanding 2012-2024 | PMD
Psychemedics shares outstanding from 2012 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
|
Psychemedics Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024 | 6 |
| 2023 | 6 |
| 2022 | 6 |
| 2021 | 6 |
| 2020 | 6 |
| 2019 | 6 |
| 2018 | 6 |
| 2017 | 6 |
| 2016 | 5 |
| 2015 | 5 |
| 2014 | 5 |
| 2013 | 5 |
| 2012 | 5 |
| 2011 | 5 |
|
Psychemedics Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024-12-31 | 6 |
| 2024-09-30 | 6 |
| 2024-06-30 | 6 |
| 2024-03-31 | 6 |
| 2023-12-31 | 6 |
| 2023-09-30 | 6 |
| 2023-06-30 | 6 |
| 2023-03-31 | 6 |
| 2022-12-31 | 6 |
| 2022-09-30 | 6 |
| 2022-06-30 | 6 |
| 2022-03-31 | 6 |
| 2021-12-31 | 6 |
| 2021-09-30 | 6 |
| 2021-06-30 | 6 |
| 2021-03-31 | 6 |
| 2020-12-31 | 6 |
| 2020-09-30 | 6 |
| 2020-06-30 | 6 |
| 2020-03-31 | 6 |
| 2019-12-31 | 6 |
| 2019-09-30 | 6 |
| 2019-06-30 | 6 |
| 2019-03-31 | 6 |
| 2018-12-31 | 6 |
| 2018-09-30 | 6 |
| 2018-06-30 | 6 |
| 2018-03-31 | 6 |
| 2017-12-31 | 6 |
| 2017-09-30 | 6 |
| 2017-06-30 | 6 |
| 2017-03-31 | 6 |
| 2016-12-31 | 5 |
| 2016-09-30 | 6 |
| 2016-06-30 | 5 |
| 2016-03-31 | 5 |
| 2015-12-31 | 5 |
| 2015-09-30 | 5 |
| 2015-06-30 | 5 |
| 2015-03-31 | 5 |
| 2014-12-31 | 5 |
| 2014-09-30 | 5 |
| 2014-06-30 | 5 |
| 2014-03-31 | 5 |
| 2013-12-31 | 5 |
| 2013-09-30 | 5 |
| 2013-06-30 | 5 |
| 2013-03-31 | 5 |
| 2012-12-31 | 5 |
| 2012-09-30 | 5 |
| 2012-06-30 | 5 |
| 2012-03-31 | 5 |
| 2011-12-31 | 5 |
| 2011-09-30 | 5 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.000B | $0.020B |
| Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.874B | 13.39 |
| Quest Diagnostics (DGX) | United States | $27.271B | 23.22 |
| DaVita (DVA) | United States | $12.368B | 15.15 |
| Encompass Health (EHC) | United States | $12.224B | 21.22 |
| Elanco Animal Health (ELAN) | United States | $11.421B | 21.57 |
| Chemed (CHE) | United States | $6.665B | 23.76 |
| RadNet (RDNT) | United States | $5.964B | 172.23 |
| LifeStance Health (LFST) | United States | $4.888B | 98.39 |
| Option Care Health (OPCH) | United States | $3.665B | 15.49 |
| Aveanna Healthcare Holdings (AVAH) | United States | $3.112B | 21.61 |
| Addus HomeCare (ADUS) | United States | $2.213B | 20.02 |
| Astrana Health (ASTH) | United States | $2.101B | 22.31 |
| Pennant (PNTG) | United States | $1.484B | 38.62 |
| U.S Physical Therapy (USPH) | United States | $1.244B | 32.83 |
| Daxor (DXR) | United States | $0.068B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.022B | 0.00 |